Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept SC in Chinese Subjects with Active Rheumatoid Arthritis
NCT02722694Phase 3Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Aug 2016
- Primary completion
- Jun 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02722694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722694.